RETRACTED: Structure–Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities (Pharmaceuticals, (2024), 17, 5, (549), 10.3390/ph17050549)

The journal retracts the article titled “Structure–Activity Relationship of Synthetic Linear KTS-Peptides Containing Meta-Aminobenzoic Acid as Antagonists of α1β1 Integrin with Anti-Angiogenic and Melanoma Anti-Tumor Activities” [1], cited above. Following publication, concerns were brought to the attention of the Editorial Office regarding a range of image irregularities contained within this article [1]. Adhering to our standard procedure, an investigation was conducted by the Editorial Office and Editorial Board that identified indications of inappropriate editing and partial duplication between figures presented in this article [1] and earlier publications [2,3], produced by a different research group. While the authors collaborated within this process, raw material meeting the journal’s requirements for original images could not be provided for Editorial Board evaluation (https://www.mdpi.com/journal/molecules/instructions#oriimages, accessed on 20 August 2025). Consequently, the Editorial Board has lost confidence in the reliability of the findings and has decided to retract this publication, as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30, accessed on 20 August 2025). This retraction was approved by the Editor-in-Chief of the Pharmaceuticals journal. Johannes A. Eble agrees to this retraction. The remaining authors disagree with this retraction.